Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06655090
Status:
RECRUITING
Last Update Posted:
None
First Post:
2022-06-28
Brief Title:
Fibrotic Interstitial Lung Disease Early Recognition and Strategic Therapy Study in China
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Fibrotic Interstitial Lung Disease Early Recognition and Strategic Therapy Study in China
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This project aimed to 1 construct a cohort of no less than 10000 cases of f-ILD including pneumoconiosis 3000 cases with continuous regular follow-up to reveal the clinical phenotypes closely related to the development progression and prognosis of pulmonary fibrosis 2 systematically evaluate the safety and effectiveness of frozen lung biopsy surgical lung biopsythoracoscopic lung biopsy and other techniques and to optimize the histological diagnosis method of f-ILD 3 construct a set of artificial intelligence AI evaluation system for quantitative evaluation of pulmonary fibrosis and its severity and develop application software 4 excavate and verify important molecular targets for the formation of pulmonary fibrosis and identify biomarkers 5 combined with clinical phenotype imaging pathology and biomarkers to establish f-ILD early recognition and progress model intervention strategies guidelines and consensus and applicated nationwide
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None